207 related articles for article (PubMed ID: 11034086)
1. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
MacCarthy-Morrogh L; Townsend PA; Purohit A; Hejaz HAM ; Potter BVL ; Reed MJ; Packham G
Cancer Res; 2000 Oct; 60(19):5441-50. PubMed ID: 11034086
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates.
Leese MP; Leblond B; Newman SP; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):239-51. PubMed ID: 15862971
[TBL] [Abstract][Full Text] [Related]
3. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours.
Purohit A; Hejaz HA; Walden L; MacCarthy-Morrogh L; Packham G; Potter BV; Reed MJ
Int J Cancer; 2000 Feb; 85(4):584-9. PubMed ID: 10699934
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate.
Singh A; Purohit A; Hejaz HA; Potter BV; Reed MJ
Mol Cell Endocrinol; 2000 Feb; 160(1-2):61-6. PubMed ID: 10715539
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
[TBL] [Abstract][Full Text] [Related]
7. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
8. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
[TBL] [Abstract][Full Text] [Related]
9. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
Jiang JD; Denner L; Ling YH; Li JN; Davis A; Wang Y; Li Y; Roboz J; Wang LG; Perez-Soler R; Marcelli M; Bekesi G; Holland JF
Cancer Res; 2002 Nov; 62(21):6080-8. PubMed ID: 12414632
[TBL] [Abstract][Full Text] [Related]
10. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
12. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
13. Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.
Blagosklonny MV; Bishop PC; Robey R; Fojo T; Bates SE
Cancer Res; 2000 Jul; 60(13):3425-8. PubMed ID: 10910051
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-targeted anticancer agents and apoptosis.
Bhalla KN
Oncogene; 2003 Dec; 22(56):9075-86. PubMed ID: 14663486
[TBL] [Abstract][Full Text] [Related]
15. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
ter Haar E; Hamel E; Balachandran R; Day BW
Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
[TBL] [Abstract][Full Text] [Related]
16. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
17. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
18. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
[TBL] [Abstract][Full Text] [Related]
19. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
20. Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells.
Liao CH; Pan SL; Guh JH; Teng CM
Biochem Pharmacol; 2004 Jun; 67(11):2031-8. PubMed ID: 15135300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]